These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25010381)

  • 1. Adjunctive Orbital Radiotherapy for Ocular Adnexal IgG4-related Disease: Preliminary Experience in Patients Refractory or Intolerant to Corticosteroid Therapy.
    Lin YH; Yen SH; Tsai CC; Kao SC; Lee FL
    Ocul Immunol Inflamm; 2015 Apr; 23(2):162-7. PubMed ID: 25010381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular adnexal IgG4-related disease: clinical features, outcome, and factors associated with response to systemic steroids.
    Yu WK; Kao SC; Yang CF; Lee FL; Tsai CC
    Jpn J Ophthalmol; 2015 Jan; 59(1):8-13. PubMed ID: 25373451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enlargement of the infraorbital nerve: an important sign associated with orbital reactive lymphoid hyperplasia or immunoglobulin g4-related disease.
    Hardy TG; McNab AA; Rose GE
    Ophthalmology; 2014 Jun; 121(6):1297-303. PubMed ID: 24613826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopsy-proven recurrence of unilateral IgG4-related orbital inflammation after 20 years.
    Heidari P; Verdijk RM; van den Bosch WA; Paridaens D
    Orbit; 2014 Oct; 33(5):388-91. PubMed ID: 24911364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular adnexal IgG4-related disease: CT and MRI findings.
    Song YS; Choung HK; Park SW; Kim JH; Khwarg SI; Jeon YK
    Br J Ophthalmol; 2013 Apr; 97(4):412-8. PubMed ID: 23385629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of IgG4-related lymphoplasmacytic infiltrative disorder in 25 patients with orbital inflammation: a retrospective case series.
    Deschamps R; Deschamps L; Depaz R; Coffin-Pichonnet S; Belange G; Jacomet PV; Vignal C; Benillouche P; Herdan ML; Putterman M; Couvelard A; Gout O; Galatoire O
    Br J Ophthalmol; 2013 Aug; 97(8):999-1004. PubMed ID: 23759440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of radiotherapy in the treatment of orbital pseudotumor.
    Matthiesen C; Bogardus C; Thompson JS; Farris B; Hildebrand L; Wilkes B; Syzek E; Algan O; Ahmad S; Herman T
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1496-502. PubMed ID: 21035962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of ocular adnexal lesions in IgG4-related ophthalmic disease.
    Kubota T; Katayama M; Nishimura R; Moritani S
    Br J Ophthalmol; 2020 Mar; 104(3):345-349. PubMed ID: 31272957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic factors in early relapse of IgG4-related orbital inflammation after steroid treatment.
    Kubota T; Katayama M; Moritani S; Yoshino T
    Am J Ophthalmol; 2013 Feb; 155(2):373-379.e1. PubMed ID: 23111178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG4-related disease in idiopathic sclerosing orbital inflammation.
    Sa HS; Lee JH; Woo KI; Kim YD
    Br J Ophthalmol; 2015 Nov; 99(11):1493-7. PubMed ID: 25947555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change of Serum IgG4 in Patients with Ocular Adnexal Marginal Zone B Cell Lymphoma Associated with IgG4-Related Ophthalmic Disease After Treatment.
    Wu YH; Wang LC; Yen SH; Yu WK; Kao SC; Kau HC; Tsai CC; Liu CJ
    J Ocul Pharmacol Ther; 2017 Sep; 33(7):543-548. PubMed ID: 28514197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy with or without surgery for patients with idiopathic sclerosing orbital inflammation refractory or intolerant to steroid therapy.
    Lee JH; Kim YS; Yang SW; Cho WK; Lee SN; Lee KJ; Ryu MR; Jang HS
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):52-8. PubMed ID: 22331004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of IgG-4-ROD on the diagnosis of orbital tumors: A retrospective analysis.
    Andron A; Hostovsky A; Nair AG; Sagiv O; Schiby G; Simon GB
    Orbit; 2017 Dec; 36(6):359-364. PubMed ID: 28829660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG4 orbital inflammation in a 5-year-old child presenting as an orbital mass.
    Kalapesi FB; Garrott HM; Moldovan C; Williams M; Ramanan A; Herbert HM
    Orbit; 2013 Apr; 32(2):137-40. PubMed ID: 23480695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab for IgG4-Related Orbital Disease.
    Karim F; Paridaens D; Westenberg LEH; Guenoun J; Verdijk RM; van Hagen PM; van Laar JAM
    Ophthalmic Plast Reconstr Surg; 2017; 33(3S Suppl 1):S162-S165. PubMed ID: 26784550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for the treatment of IgG4-related orbital disease: experience from five cases.
    Wu A; Andrew NH; Tsirbas A; Tan P; Gajdatsy A; Selva D
    Eye (Lond); 2015 Jan; 29(1):122-8. PubMed ID: 25341435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis of IgG4-related systemic disease in a patient with an ocular tumor associated with lung nodules].
    Vandenbos F; Benchetrit M; Tieulié N; Ambrosetti D; Chanalet S; Burel-Vandenbos F
    Rev Pneumol Clin; 2012 Dec; 68(6):370-3. PubMed ID: 23159548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review.
    Wallace ZS; Deshpande V; Stone JH
    Semin Arthritis Rheum; 2014 Jun; 43(6):806-17. PubMed ID: 24513111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralesional corticosteroid injections as treatment for non-infectious orbital inflammation.
    Reggie S; Neimkin M; Holds J
    Orbit; 2018 Feb; 37(1):41-47. PubMed ID: 28872378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.
    Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ
    Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.